Reitox network

Drug-related infectious diseases (DRID): update from the expert network, October 2021

The objectives of the Drug-related infectious diseases (DRID) network are to share the latest developments on drug-related infectious diseases in Europe and to identify steps needed to improve the production, availability and...

Cover of report — national drug report 2020 of Luxembourg

Document library

Luxembourg national drug report 2020

This report presents an overview of the drug phenomenon in Luxembourg, covering drug policy, drug supply and demand, drug use patterns, health consequences and responses, as well as drug markets and crime...

Graphic shows a series of pie charts for cannabis, cocaine, MDMA and amphetamines, showing drug prevalance rates in the EU. Cannabis is the most used drug with 7.7% of adults having used it in the last year. Last year use for cocaine is 1.2%, MDMA is 0.9%

At a glance — estimates of drug use in the European Union (updated June 2022)

Graphic shows estimates of prevalence of use for different drugs in the European Union (EU-27). This graphic is take from the European Drug Report 2021. Full source data and methods and...

Video Screenshot of Sandrine Sleiman

Spotlight on our activities: Reitox network

Hear how the COVID-19 pandemic highlighted the strength of the Reitox network, how the cooperation continued through this crisis and what additional activities focal points launched. This is the seventh contribution in...

infographic showing residues of different drugs found in syringes from selected European cities, 2019

Drug residues in used syringes in selected European cities, 2019

Graphic showing location of sites (Glasgow, Amsterdam, Paris, Lausanne, Budapest, Helsinki) for the 2017 pilot study of the ESCAPE (European Syringe Collection and Analysis Project Enterprise) project.

Publication thumbnail

Reitox national focal points’ activities during the COVID-19 pandemic

This report highlights the responses taken by the EMCDDA's Reitox network of national focal points to the COVID-19 crisis and describes the challenges met by the organisations and the strategies produced to...

Viktor Mravcik

EMCDDA Voices: Viktor Mravcik

To celebrate our ‘25 years of monitoring’ milestone, we invited our team and wider community to join us on a digital storytelling journey and tell us what the EMCDDA means to them...

publication cover

European Drug Report 2020: Key Issues

This report, available in 24 languages, presents a summary of some the main findings of the 'European Drug Report 2020: Trends and Developments the EMCDDA’s latest analysis of the drug situation in...

European Drug Report 2020: Trends and Developments

This report provides a comprehensive analysis of patterns emerging across Europe in the areas of drug supply, illicit drug use and associated public health problems. National data sets are also provided across...

Publication cover

EMCDDA Trendspotter briefing: impact of COVID-19 on patterns of drug use and drug-related harms in Europe

Since the start of 2020, European countries have been experiencing an unprecedented public health threat with the emergence of the coronavirus disease (COVID-19). In order to investigate the effects and implications of...

Subscribe to Reitox network